| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | 0.056 | 0.09 |
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.09 |
| mRNA | DBeQ | CTRPv2 | pan-cancer | AAC | 0.063 | 0.09 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | -0.079 | 0.09 |
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.09 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.063 | 0.1 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | 0.062 | 0.1 |
| mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | -0.092 | 0.1 |
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.061 | 0.1 |
| mRNA | BMS-345541 | CTRPv2 | pan-cancer | AAC | 0.061 | 0.1 |